A three-dimensional engineered artery model for in vitro atherosclerosis research.
The pathogenesis of atherosclerosis involves dysfunctions of vascular endothelial cells and smooth muscle cells as well as blood borne inflammatory cells such as monocyte-derived macrophages. In vitro experiments towards a better understanding of these dysfunctions are typically performed in two-dim...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/532beecce7fe400fba125ef0b2a2aa49 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:532beecce7fe400fba125ef0b2a2aa49 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:532beecce7fe400fba125ef0b2a2aa492021-11-18T08:46:29ZA three-dimensional engineered artery model for in vitro atherosclerosis research.1932-620310.1371/journal.pone.0079821https://doaj.org/article/532beecce7fe400fba125ef0b2a2aa492013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24244566/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203The pathogenesis of atherosclerosis involves dysfunctions of vascular endothelial cells and smooth muscle cells as well as blood borne inflammatory cells such as monocyte-derived macrophages. In vitro experiments towards a better understanding of these dysfunctions are typically performed in two-dimensional cell culture systems. However, these models lack both the three-dimensional structure and the physiological pulsatile flow conditions of native arteries. We here describe the development and initial characterization of a tissue engineered artery equivalent, which is composed of human primary endothelial and smooth muscle cells and is exposed to flow in vitro. Histological analyses showed formation of a dense tissue composed of a tight monolayer of endothelial cells supported by a basement membrane and multiple smooth muscle cell layers. Both low (LDL) and high density lipoproteins (HDL) perfused through the artery equivalent were recovered both within endothelial cells and in the sub-endothelial intima. After activation of the endothelium with either tumour necrosis factor alpha (TNFα) or LDL, monocytes circulated through the model were found to adhere to the activated endothelium and to transmigrate into the intima. In conclusion, the described tissue engineered human artery equivalent model represents a significant step towards a relevant in vitro platform for the systematic assessment of pathogenic processes in atherosclerosis independently of any systemic factors.Jérôme RobertBenedikt WeberLaura FreseMaximilian Y EmmertDörthe SchmidtArnold von EckardsteinLucia RohrerSimon P HoerstrupPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e79821 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Jérôme Robert Benedikt Weber Laura Frese Maximilian Y Emmert Dörthe Schmidt Arnold von Eckardstein Lucia Rohrer Simon P Hoerstrup A three-dimensional engineered artery model for in vitro atherosclerosis research. |
| description |
The pathogenesis of atherosclerosis involves dysfunctions of vascular endothelial cells and smooth muscle cells as well as blood borne inflammatory cells such as monocyte-derived macrophages. In vitro experiments towards a better understanding of these dysfunctions are typically performed in two-dimensional cell culture systems. However, these models lack both the three-dimensional structure and the physiological pulsatile flow conditions of native arteries. We here describe the development and initial characterization of a tissue engineered artery equivalent, which is composed of human primary endothelial and smooth muscle cells and is exposed to flow in vitro. Histological analyses showed formation of a dense tissue composed of a tight monolayer of endothelial cells supported by a basement membrane and multiple smooth muscle cell layers. Both low (LDL) and high density lipoproteins (HDL) perfused through the artery equivalent were recovered both within endothelial cells and in the sub-endothelial intima. After activation of the endothelium with either tumour necrosis factor alpha (TNFα) or LDL, monocytes circulated through the model were found to adhere to the activated endothelium and to transmigrate into the intima. In conclusion, the described tissue engineered human artery equivalent model represents a significant step towards a relevant in vitro platform for the systematic assessment of pathogenic processes in atherosclerosis independently of any systemic factors. |
| format |
article |
| author |
Jérôme Robert Benedikt Weber Laura Frese Maximilian Y Emmert Dörthe Schmidt Arnold von Eckardstein Lucia Rohrer Simon P Hoerstrup |
| author_facet |
Jérôme Robert Benedikt Weber Laura Frese Maximilian Y Emmert Dörthe Schmidt Arnold von Eckardstein Lucia Rohrer Simon P Hoerstrup |
| author_sort |
Jérôme Robert |
| title |
A three-dimensional engineered artery model for in vitro atherosclerosis research. |
| title_short |
A three-dimensional engineered artery model for in vitro atherosclerosis research. |
| title_full |
A three-dimensional engineered artery model for in vitro atherosclerosis research. |
| title_fullStr |
A three-dimensional engineered artery model for in vitro atherosclerosis research. |
| title_full_unstemmed |
A three-dimensional engineered artery model for in vitro atherosclerosis research. |
| title_sort |
three-dimensional engineered artery model for in vitro atherosclerosis research. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/532beecce7fe400fba125ef0b2a2aa49 |
| work_keys_str_mv |
AT jeromerobert athreedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT benediktweber athreedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT laurafrese athreedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT maximilianyemmert athreedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT dortheschmidt athreedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT arnoldvoneckardstein athreedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT luciarohrer athreedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT simonphoerstrup athreedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT jeromerobert threedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT benediktweber threedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT laurafrese threedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT maximilianyemmert threedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT dortheschmidt threedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT arnoldvoneckardstein threedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT luciarohrer threedimensionalengineeredarterymodelforinvitroatherosclerosisresearch AT simonphoerstrup threedimensionalengineeredarterymodelforinvitroatherosclerosisresearch |
| _version_ |
1718421321468084224 |